CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in CalciMedica, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- 0 vs. Q1 2025
- Shares held
- 3.73M
- −241.9K (−6.1%) vs. Q1 2025
- Total value
- $5.93M
- −$1.57M (−20.9%) vs. Q1 2025
- New holders
- 4
- 10 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 19 | $30 | 0.00% | +19 | New |
| SBI Securities Co., Ltd. | 121 | $194 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 200 | $320 | 0.00% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 308 | $471 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 536 | $820 | 0.00% | +536 | New |
| Morgan Stanley | 856 | $1.37K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,936 | $4.70K | 0.00% | +117+4.2% | Added |
| Tower Research Capital LLC (TRC) | 2,993 | $4.79K | 0.00% | +11+0.4% | Added |
| Bank of America Corp | 9,040 | $14.5K | 0.00% | +17+0.2% | Added |
| First Manhattan Co | 13,226 | $21.2K | 0.00% | 00.0% | Unchanged |
| Weaver Consulting Group | 13,393 | $21.4K | 0.01% | +13,393 | New |
| Tritonpoint Wealth, LLC | 15,119 | $24.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 17,003 | $27.2K | 0.00% | +16,783+7,628.6% | Added |
| J. Goldman & Co LP | 18,900 | $30.2K | 0.00% | 00.0% | Unchanged |
| Sound View Wealth Advisors Group, LLC | 20,100 | $32.2K | 0.00% | +20,100 | New |
| Renaissance Technologies LLC | 36,000 | $57.6K | 0.00% | +584+1.6% | Added |
| Cetera Investment Advisers | 36,385 | $58.2K | 0.00% | +9,045+33.1% | Added |
| CI Private Wealth, LLC | 38,000 | $60.8K | 0.00% | 00.0% | Unchanged |
| Atria Investments LLC | 44,700 | $71.5K | 0.00% | +7,436+20.0% | Added |
| Meritage Portfolio Management | 46,000 | $73.6K | 0.00% | 00.0% | Unchanged |
| 180 Wealth Advisors, LLC | 50,450 | $80.7K | 0.01% | +34,050+207.6% | Added |
| Millennium Management LLC | 52,870 | $80.9K | 0.00% | −6,518−11.0% | Reduced |
| Stonepine Capital Management, LLC | 85,000 | $136.0K | 0.13% | −282,371−76.9% | Reduced |
| Wealthedge Investment Advisors, LLC | 87,468 | $139.9K | 0.06% | −20,823−19.2% | Reduced |
| Geode Capital Management, LLC | 97,032 | $148.5K | 0.00% | +650+0.7% | Added |
| Envestnet Asset Management Inc | 93,433 | $149.5K | 0.00% | +34,386+58.2% | Added |
| Vanguard Group Inc | 339,148 | $518.9K | 0.00% | 00.0% | Unchanged |
| Aisling Capital Management LP | 521,114 | $833.8K | 0.23% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 783,904 | $1.25M | 0.09% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,300,000 | $2.08M | 0.04% | 00.0% | Unchanged |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −30,385−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −23,539−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −15,407−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −15−100.0% | Sold out |